Does Surveillance-Detected Disease Progression Yield Superior Patient Outcomes in High-Grade Glioma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does Surveillance-Detected Disease Progression Yield Superior Patient Outcomes in High-Grade Glioma?

Published:2020-03 Issue: Volume:135 Page:e410-e417
ISSN:1878-8750
Container-title:World Neurosurgery
language:en
Short-container-title:World Neurosurgery

Author:

Monroe Courtney L.,Travers Sarah,Woldu Henok G.,Litofsky N. Scott

Funder

University of Missouri Research Council Summer Research

Head for the Cure Foundation

Publisher

Elsevier BV

Subject

Neurology (clinical),Surgery

Reference44 articles.

1. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: a population-based study;Zhu;Oncotarget,2017

2. Time trends in glioblastoma multiforme survival: the role of temozolomide;Dubrow;Neuro Oncol,2013

3. Survival improvements with adjuvant therapy in patients with glioblastoma;Jayamanne;ANZ J Surg,2018

4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

5. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of MRI Follow-Up on Treatment Decisions during Standard Concomitant and Adjuvant Chemotherapy in Patients with Glioblastoma: Is Less More?;Cancers;2023-10-13

2. The patients’ experience of neuroimaging of primary brain tumors: a cross-sectional survey study;Journal of Neuro-Oncology;2023-03-28

3. The Patients’ Experience of Neuroimaging of Primary Brain Tumours: A Cross-Sectional Survey Study;2023-02-14

4. Is there an optimal MRI surveillance schedule for patients with high-grade glioma after standard-of-care-therapy?;Neuro-Oncology;2021-03-01

5. Radiological assessment schedule for high-grade glioma patients during the surveillance period using parametric modeling;Neuro-Oncology;2020-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3